These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23692026)

  • 1. Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
    Verburg FA; Luster M; Cupini C; Chiovato L; Duntas L; Elisei R; Feldt-Rasmussen U; Rimmele H; Seregni E; Smit JW; Theimer C; Giovanella L
    Thyroid; 2013 Oct; 23(10):1211-25. PubMed ID: 23692026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer.
    Jo K; Lim DJ
    Korean J Intern Med; 2018 Nov; 33(6):1050-1057. PubMed ID: 30396251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
    Spencer CA
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroglobulin antibody status and differentiated thyroid cancer: what does it mean for prognosis and surveillance?
    Gianoukakis AG
    Curr Opin Oncol; 2015 Jan; 27(1):26-32. PubMed ID: 25390556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
    Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
    J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
    Lupoli GA; Okosieme OE; Evans C; Clark PM; Pickett AJ; Premawardhana LD; Lupoli G; Lazarus JH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):100-8. PubMed ID: 25322272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating Antithyroglobulin Antibody As a Prognostic Marker for Differentiated Thyroid Cancer: A Meta-Analysis and Systematic Review.
    Lee ZJO; Eslick GD; Edirimanne S
    Thyroid; 2020 Nov; 30(11):1601-1612. PubMed ID: 32345152
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
    Spencer C
    Thyroid; 2013 Oct; 23(10):1190-2. PubMed ID: 23987661
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
    Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
    Zhang W; Deng H; Pan M; Huang R; Tang G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
    Spencer C; Fatemi S
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
    Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
    Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.
    Kim WG; Yoon JH; Kim WB; Kim TY; Kim EY; Kim JM; Ryu JS; Gong G; Hong SJ; Shong YK
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4683-9. PubMed ID: 18812478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma.
    Qin J; Yu Z; Guan H; Shi L; Liu Y; Zhao N; Shan Z; Han C; Li Y; Teng W
    Dis Markers; 2015; 2015():648670. PubMed ID: 26600670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thyroglobulin in the monitoring of differentiated thyroid cancer.
    Evans C; Tennant S; Perros P
    Scand J Clin Lab Invest Suppl; 2016; 245():S119-23. PubMed ID: 27542000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The correlation between endogenous TgAb and experimental Tg values in patients with differentiated thyroid carcinomas].
    Tang GS; Xu J; Yu Y; Pan MZ; Wang JR; Yuan LP; Jiang T; Huang F; Jing CL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):856-60. PubMed ID: 22332559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas.
    Spencer CA; Bergoglio LM; Kazarosyan M; Fatemi S; LoPresti JS
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5566-75. PubMed ID: 15985472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies.
    Spencer C; LoPresti J; Fatemi S
    Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):394-404. PubMed ID: 25122493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
    Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
    Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer.
    Rubello D; Girelli ME; Casara D; Piccolo M; Perin A; Busnardo B
    J Endocrinol Invest; 1990 Oct; 13(9):737-42. PubMed ID: 2292657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.